This study funded by the National Institutes of Health (NIH) and published in the journal Diabetes Care reaffirms the interest in certain groups of patients, of bariatric surgery, here by the installation of a gastric band to prevent pre-diabetes and reduce type 2 diabetes. Data that even seem to indicate a superiority of surgery, at least for weight loss, but also the management of diabetes, over drugs.
According to the NIH study, patients with prediabetes or type 2 diabetes who underwent this type of bariatric surgery to lose weight show stabilization of their disease.
This is the analysis of data from the Beta Cell Restoration through Fat Mitigation study (BetaFat), conducted at the University of Southern California, Los Angeles as part of a larger project, the Restoring program Insulin Secretion (RISE). The BetaFat study examines the restoration of beta cells via fat reduction, in 88 participants with mild to moderate obesity and prediabetes or recent type 2 diabetes. Half of the participants were assigned to the gastric banding procedure, which involves slowing digestion with a band placed around the upper part of the stomach, the other participants were given metformin,
Gastric banding, weight loss and reduction in markers of diabetes: After 2 years, participants in the "gastric banding" group lost a lot of weight, averaging more than 10 kilos, compared to just under 2 kilos in the “metformin” group. Both groups resulted in similar improvements in insulin sensitivity and relatively stable function of insulin-producing cells, with small improvements in blood sugar levels.
Thus, the bariatric procedure not only resulted in significant weight loss but resulted in the same improvements in insulin sensitivity.
.jpg)
